DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous glucose monitoring system in adults with Type 2 diabetes not using insulin. The company introduced ...
Apple and Samsung may not need glucose-sensing smartwatches to compete in health AI. The next race is turning CGM data into ...
Oura Ring uses Stelo by Dexcom to show glucose patterns, meal responses, and Time Above Range for users tracking blood sugar ...
Tech companies are evolving their health trackers to make them smaller, thinner, and near-invisible. Here's why.
AI is reshaping diagnostics. Surgical robotics gains attention. Monitoring devices grow smarter. AI is reshaping healthcare devices through smarter diagnostics, robotic surgery, connected monitoring, ...
Learn how Apple Watch supports diabetes management with CGM glucose readings, Apple Health records, medication reminders, ...
According to MarketsandMarkets, the Patient Monitoring Devices Market is projected to grow from about USD 55.60 billion in 2026 to USD 76.11 ...
Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...
Zacks Investment Research on MSN
Dexcom reports positive CONNECT data for non-insulin diabetes
DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...
A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results